Ownership

Mark Lappe - Chief Executive Officer, Director at Inhibrx Biosciences, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: INBX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Mark Lappe - trading volume in the past year for Inhibrx Biosciences, Inc.

	Shares	%	Avg Price	Total $
Buys	+164K	100%	$14.73	+$2.42M
Sells
Net	+164K	100%		+$2.42M

Holdings reported by Mark Lappe for Inhibrx Biosciences, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	706K	$12.1M	$17.13	Sep 16, 2024	By the Lappe Family Trust
Common Stock	165K	$2.83M	$17.13	Sep 12, 2024	By Lappe Descendants' Trust
Common Stock	54.9K	$940K	$17.13	Sep 12, 2024	The Mark Paul Lappe Roth IRA
Stock Option (right to buy)	300K			May 30, 2024	Direct	Common Stock

Transactions reported by Mark Lappe for Inhibrx Biosciences, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.